Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - World Heart Corporation (NasdaqNM:WHRT)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs | Reports
Location
1 Laser Street, Ontario
Ottawa, K2E 7V1, Canada
Phone: (613) 226-4278
Fax: (613) 226-4744
Email: investors@worldheart.com
Employees (last reported count): 77
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 68%
·Institutional: 7% (23% of float)
(11 institutions)
·Net Inst. Buying: 270.0K shares (+19.40%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
World Heart Corp. focuses on the development of HeartSaver VAD and Novacor LVAS to provide an effective treatment for end-stage heart failure. Ventricular assist devices (VADs) are mechanical assist devices that supplement the circulatory function of the heart by rerouting blood flow through a mechanical pump. The Novacor LVAS represents the current generation of pulsatile ventricular assist devices, with HeartSaver as the next generation of fully implantable pulsatile VADs. HeartSaver is designed to be an affordable, fully implantable heart assist device to provide long-term support of pulsatile blood flow to people suffering from heart failure and to permit the recipient to return to near normal activities. Commencement of clinical trials in humans is planned for the fourth quarter of 2001, subject to Health Canada approval. Subject to regulatory approval, commercial production of HeartSaver is planned for 2002.
More from Market Guide: Expanded Business Description

Financial Summary
World Heart Corporation was formed for the purpose of developing a medical devices business based initially on licensed artificial heart and related technologies developed by the Cardiovascular Devices Division of the Ottawa Heart Research Corporation. For the six months ended 6/30/01, revenues totaled C$2.8 million, up from C$0. Net loss totaled C28.2 million, up from C$8.5 million. Results reflect the acquisition of Novacor, offset by increased R&D and amortization costs.
More from Market Guide: Significant Developments

Officers
FY1998 Pay

Roderick Bryden
Chairman and CEO
$156K
Tofy Mussivand
Pres, COO
298K
Robert Corson
Exec. VP - Opertions
204K
Ian Malone
VP - Fin., CFO
214K
W. Keys
VP, Gen. Counsel and Sec.
--  
Dollar amounts are as of 31-Dec-1998 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:WHRTAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$3.813
Recent Price$5.68 
52-Week High
on 5-Sep-2000
$10.625
Beta0.12 
Daily Volume (3-month avg)6,000 
Daily Volume (10-day avg)6,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-46.2%
52-Week Change
relative to S&P500
-27.9%
Share-Related Items
Market Capitalization$85.9M
Shares Outstanding15.1M
Float4.80M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.83 
Earnings (ttm)-$2.13 
Earnings (mrq)-$0.65 
Sales (ttm)$0.32 
Cash (mrq)$1.06 
Valuation Ratios
Price/Book (mrq)6.83 
Price/EarningsN/A 
Price/Sales (ttm)17.61 
Income Statements
Sales (ttm)$4.84M
EBITDA (ttm)-$26.9M
Income available to common (ttm)-$32.0M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-42.87%
Return on Equity (ttm)-160.73%
Financial Strength
Current Ratio (mrq)3.87 
Debt/Equity (mrq)0.02 
Total Cash (mrq)$16.1M
Short Interest
As of 8-Aug-2001
Shares Short68.0K
Percent of Float1.4%
Shares Short
(Prior Month)
62.0K
Short Ratio9.71 
Daily Volume7,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001);   dollar amounts based on an exchange rate of 1.55 Canadian Dollars/US Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.